Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis.
Song N, Xu H, Liu J, Zhao Q, Chen H, Yan Z, Yang R, Luo Z, Liu Q, Ouyang J, Wu S, Luo S, Ye S, Lin R, Sun X, Xie J, Lan T, Wu Z, Wang R, Jiang X.
Song N, et al. Among authors: xu h.
Acta Pharm Sin B. 2022 May;12(5):2443-2461. doi: 10.1016/j.apsb.2021.12.016. Epub 2021 Dec 29.
Acta Pharm Sin B. 2022.
PMID: 35646543
Free PMC article.